ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 680

$1.91M Total Retail Price of All Prescriptions

Rank: 8 out of 680

1,086 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,086 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 1,086 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

6% of this provider’s 33,597 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 1,654 1,502 1 6
HYDROCODONE-ACETAMINOPHEN 1,276 877 S3 2 4
LEVOTHYROXINE SODIUM 968 858 3 2
TRAMADOL HCL 960 907 4 18
OMEPRAZOLE 954 851 5 7
SIMVASTATIN 914 804 6 3
METFORMIN HCL 800 685 7 8
ENALAPRIL MALEATE 725 656 8 65
NEXIUM 666 566 9 16
DONEPEZIL HCL 656 624 10 27
AMLODIPINE BESYLATE 654 625 11 1
MELOXICAM 609 504 12 24
AMLODIPINE BESYLATE-BENAZEPRIL 585 515 10 13 43
SERTRALINE HCL 542 460 14 28
ZOLPIDEM TARTRATE 535 457 15 17
DOXYCYCLINE HYCLATE 522 473 16 95
POTASSIUM CHLORIDE 478 411 17 14
NABUMETONE 460 423 18 174
GABAPENTIN 456 355 19 15
LISINOPRIL 429 375 20 5
NAMENDA 426 423 21 35
DIOVAN 417 396 22 31
HYDROCHLOROTHIAZIDE 338 294 23 9
LACTULOSE 328 304 24 92
DIGOXIN 319 294 25 58
POLYETHYLENE GLYCOL 3350 313 297 26 62
ESCITALOPRAM OXALATE 307 287 27 45
QUETIAPINE FUMARATE 304 294 28 64
CRESTOR 295 256 29 25
GLYBURIDE MICRONIZED 291 260 R 30 232
METOPROLOL TARTRATE 286 267 31 12
CYMBALTA 285 257 32 46
WARFARIN SODIUM 285 244 32 20
MEGESTROL ACETATE 269 258 R 34 88
CARVEDILOL 264 237 35 23
CLOPIDOGREL 259 245 36 26
JANTOVEN 258 243 37 147
SULFAMETHOXAZOLE-TRIMETHOPRIM 252 239 38 94
MECLIZINE HCL 242 222 39 103
TAMSULOSIN HCL 241 213 40 34
SINGULAIR 240 205 41 91
PRAVASTATIN SODIUM 237 216 42 10
GLYBURIDE-METFORMIN HCL 234 201 R 43 107
DIPYRIDAMOLE 224 215 R 44 303
CIPROFLOXACIN HCL 214 198 45 57
CITALOPRAM HBR 200 198 46 22
ATORVASTATIN CALCIUM 199 187 47 11
CLONIDINE HCL 196 166 48 36
NOVOLIN 70-30 191 177 49 236
KLOR-CON M20 190 174 50 61
AMITRIPTYLINE HCL 188 184 R 51 47
PREMARIN 188 155 R 51 105
SEROQUEL 187 169 53 123
LYRICA 186 153 54 77
CARBIDOPA-LEVODOPA 180 180 55 117
PLAVIX 179 172 56 39
ALLOPURINOL 179 143 56 33
NOVOLIN R 170 158 58 113
CEFADROXIL 166 142 59 261
ATENOLOL 166 147 59 19
METOPROLOL SUCCINATE 164 151 61 13
DOXAZOSIN MESYLATE 162 139 62 73
GLIMEPIRIDE 160 147 63 29
PROPRANOLOL HCL 155 128 64 145
GLYBURIDE 155 140 R 64 85
CYCLOBENZAPRINE HCL 154 103 R 66 81
ADVAIR DISKUS 151 142 67 53
RANITIDINE HCL 150 130 68 56
LANTUS 149 139 69 49
CARISOPRODOL 149 31 R 69 83
METOCLOPRAMIDE HCL 148 115 71 118
LEXAPRO 146 141 72 128
ALENDRONATE SODIUM 137 134 73 32
TORSEMIDE 136 136 74 163
METOLAZONE 131 111 75 201
PANTOPRAZOLE SODIUM 130 119 76 30
BACLOFEN 125 81 77 140
PAROXETINE HCL 125 120 77 76
LOVASTATIN 123 112 79 44
EXELON 122 122 80 112
DESOXIMETASONE 120 98 81 379
TRICOR 120 110 81 98
HUMULIN R 119 117 83 195
MONTELUKAST SODIUM 115 97 84 157
NAPROXEN 113 96 85 121
COMBIVENT 111 110 86 168
FLUTICASONE PROPIONATE 109 103 87 41
SYNTHROID 109 105 87 38
NOVOLIN N 108 100 89 225
SUCRALFATE 107 94 90 160
NIFEDIPINE ER 107 102 90 75
BENAZEPRIL HCL 102 102 92 40
INSULIN SYRINGE 99 91 93 86
PRAMIPEXOLE DIHYDROCHLORIDE 98 85 94 204
OXYBUTYNIN CHLORIDE ER 98 90 94 143
OXYBUTYNIN CHLORIDE 96 81 96 129
DIOVAN HCT 96 88 96 55
ENABLEX 95 95 98 217
HYDROXYZINE HCL 90 86 R 99 267
VESICARE 89 71 100 176
CLOTRIMAZOLE-BETAMETHASONE 88 86 101 138
CELEBREX 84 78 102 90
TRAZODONE HCL 83 70 103 48
PREDNISONE 81 77 104 50
MUPIROCIN 81 68 104 130
NITROFURANTOIN MONO-MACRO 79 66 106 172
BUMETANIDE 79 65 106 102
RAMIPRIL 78 65 108 69
ALBUTEROL SULFATE 77 76 109 154
LIPITOR 77 71 109 68
SPIRONOLACTONE 77 64 109 82
NITROGLYCERIN PATCH 76 76 112 271
ACTOS 76 56 112 114
VOLTAREN 76 72 112 253
TRIAMTERENE-HCTZ 75 75 115 52
PROAIR HFA 75 66 115 67
TERAZOSIN HCL 75 75 115 180
MIRTAZAPINE 73 73 118 78
GLIPIZIDE 72 62 119 63
ROPINIROLE HCL 72 71 119 99
DICYCLOMINE HCL 71 67 121 278
BUSPIRONE HCL 71 71 121 144
LOSARTAN POTASSIUM 70 67 123 21
METHYLPREDNISOLONE 70 53 123 93
AMIODARONE HCL 69 69 125 158
PHENYTOIN SODIUM EXTENDED 69 62 125 115
RISPERIDONE 68 66 127 80
AZITHROMYCIN 67 59 128 42
ISOSORBIDE MONONITRATE ER 65 65 129 59
GEMFIBROZIL 64 42 130 106
CARAFATE 64 61 130 273
DIVALPROEX SODIUM 64 50 130 110
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 60 130 37
CILOSTAZOL 62 58 134 230
FENOFIBRATE 61 60 135 66
NATEGLINIDE 61 53 135 224
FINASTERIDE 60 60 137 109
ENALAPRIL-HYDROCHLOROTHIAZIDE 60 60 137 350
HUMULIN 70-30 60 60 137 277
JANUVIA 59 59 140 60
SAVELLA 58 48 141 433
FLUCONAZOLE 55 49 142 139
MEGACE ES 53 53 R 143 280
QUINAPRIL HCL 53 39 143 104
BUPROPION XL 52 52 145 161
ZETIA 50 49 146 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.